SOFOSBUVIR AND NS5A INHIBITORS WITHOUT RIBAVIRIN DURING 12 WEEKS ARE EFFICIENT TO TREAT HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION ONLY IN GENOTYPE 1. RESULTS FROM THE CO23 ANRS CUPILT STUDY

Affiliation auteurs!!!! Error affiliation !!!!
TitreSOFOSBUVIR AND NS5A INHIBITORS WITHOUT RIBAVIRIN DURING 12 WEEKS ARE EFFICIENT TO TREAT HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION ONLY IN GENOTYPE 1. RESULTS FROM THE CO23 ANRS CUPILT STUDY
Type de publicationJournal Article
Year of Publication2017
AuteursHoussel-Debry P., Coilly A., Fougerou-Leurent C., Jezequel C., Duvoux C., De Ledinghen V., Radenne S., Kamar N., Leroy V., Di Martino V., D'alteroche L., Canva V., Conti F., Dumortier J., Montialoux H., Lebray P., Botta-Fridlund D., Anty R., Moreno C., Silvain C., Besch C., Perre P., Francoz C., Abergel A., Habersetzer F., Debette-Gratien M., Rohel A., Diallo A., Rossignol E., Veislinger A., Danjou H., Duclos-Vallee J.C, Pageaux G.P
JournalTRANSPLANT INTERNATIONAL
Volume30
Pagination25
Date PublishedJAN
Type of ArticleMeeting Abstract
ISSN0934-0874